Infection in Kidney Transplantation

  • Puja NambiarEmail author
  • Randi Silibovsky
  • Katherine A. Belden
Reference work entry
Part of the Organ and Tissue Transplantation book series (OTT)


Infection is an important cause of morbidity and mortality after kidney transplantation. It has been estimated that 70% of kidney transplant recipients will experience an infection episode within the first 3 years after transplantation (Dharnidharka et al. 2007). After cardiovascular disease, infection is the second leading cause of death in recipients with allograft function (Snyder et al. 2009). The immunosuppressive therapy required to prevent organ rejection places the kidney transplant recipient at increased risk for donor-derived, nosocomial, and community-acquired infections as well as reactivation of latent pathogens. Pretransplant screening, immunizations, and optimal antibacterial and antiviral prophylaxis can help to reduce the impact of infection. Awareness of the approach to infection in the transplant recipient including diagnostic and management strategies is essential to optimizing outcomes.


Renal transplant Solid organ transplant Immunocompromised host Viral Bacterial Fungal Atypical infections 


  1. Abbott KC, Oliver JD 3rd, Hypolite I, Lepler LL, Kirk AD, Ko CW, Hawkes CA, Jones CA, Agodoa LY (2001) Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Nephrol 21(2):120–127PubMedCrossRefGoogle Scholar
  2. Allen U, Preiksaitis J, AST Infectious Diseases Community of Practice (2009) Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients. Am J Transplant 9(Suppl 4):S87–S96PubMedCrossRefGoogle Scholar
  3. Alsaad KL, Tobar A, Belanger E, Ahmad M, Cattran DC, Herzenberg AM (2007) Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograft. Nephrol Dial Transplant 22:1257–1260PubMedCrossRefGoogle Scholar
  4. Arduino RC, Johnson PC, Miranda AG (1993) Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis 16(4):505–512PubMedCrossRefGoogle Scholar
  5. Asberg A, Humar A, Jardine AG, Rollag H, Pescovitz MD, Mouas H, Bignamini A, Toz H, Dittmer I, Montejo M, Hartmann A, VICTOR Study Group (2009) Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant 9:1205–1213PubMedCrossRefGoogle Scholar
  6. Ashry Ahmed Gheith O (2011) Dilemma of HCV infection in renal transplant recipients. Int J Nephrol 2011:471214PubMedPubMedCentralCrossRefGoogle Scholar
  7. Barry A, Gunn J, Tormey P et al (2008) Lymphocytic choriomeningitis virus transmitted through solid organ transplantation – Massachusetts, 2008. MMWR Morb Mortal Wkly Rep 57:799–801Google Scholar
  8. Blumberg EA, Stock P, AST Infectious Diseases Community of Practice (2009) Solid organ transplantation in the HIV-infected patient. Am J Transplant 9(Suppl 4):S131–S135PubMedCrossRefGoogle Scholar
  9. Brennan DC (2001) Cytomegalovirus in renal transplantation. J Am Soc Nephrol 12:848–855PubMedGoogle Scholar
  10. Carter JT, Melcher ML, Carlson LL, Roland ME, Stock PG (2006) Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients. Am J Transplant 6:753–760PubMedCrossRefGoogle Scholar
  11. Centers for Disease Control and Prevention (2011) HIV transmitted from a living organ donor-New York City, 2009. Morb Mortal Wkly Rep 60:297–301Google Scholar
  12. Centers for Disease Control and Prevention (CDC) (2012) Recommended adult immunization schedule-United States. MMWR Morb Mortal Wkly Rep 61(4):66–72Google Scholar
  13. Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK (2002) Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology 36:1246–1252PubMedCrossRefGoogle Scholar
  14. Chang TT, Lai CL, Kew Yoon S, Lee SS, Coelho HS, Carrilho FJ, Poordad F, Halota W, Horsmans Y, Tsai N, Zhang H, Tenney DJ, Tamez R, Iloeje U (2010) Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology 51:422–430PubMedCrossRefGoogle Scholar
  15. Chapenko S, Folkmane I, Tomsone V, Amerika D, Rozentals R, Murovska M (2000) Co-infection of two β-herpesviruses (CMV and HHV-7) as an increased risk factor for “CMV disease” in patients undergoing renal transplantation. Clin Transpl 14(5):486–492CrossRefGoogle Scholar
  16. Ciuffreda D, Pantaleo G, Pascual M (2007) Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation. Transpl Int 20:649–658PubMedCrossRefGoogle Scholar
  17. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA (1993) Post-transplant lymphoproliferative disorder in renal allograft recipients: clinical experience and risk factor analysis in a single center. Transplantation 56:88–96PubMedCrossRefGoogle Scholar
  18. Coussement J, Abramowicz D (2013) Should we treat asymptomatic bacteriuria after renal transplantation? Nephrol Dial Transplant 29:1–3CrossRefGoogle Scholar
  19. Dadhania D, Snopkowski C, Ding R, Muthukumar T, Chang C, Aull M, Lee J, Sharma VK, Kapur S, Suthanthiran M (2008) Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation 86:521–528PubMedPubMedCentralCrossRefGoogle Scholar
  20. De Keyzer K, Van Laecke S, Peeters P, Vanholder R (2011) Human cytomegalovirus and kidney transplantation: a clinician’s update. Am J Kidney Dis 58:118–126PubMedCrossRefGoogle Scholar
  21. Dharnidharka VR, Agodoa LY, Abbott KC (2007) Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients-an analysis of USRDS data. Am J Transplant 7:653–661PubMedCrossRefGoogle Scholar
  22. DiazGranados CA, Dunning AJ et al (2014) Efficacy of high-dose versus standard-dose influenza vaccine in older adults. NEJM 371:635–645PubMedCrossRefGoogle Scholar
  23. Diociaiuti A, Nanni G, Cattani P, Lesnoni La Parola I, Masini CM, Pozzetto U, Fadda G, Castagneto M, Cerimele D (2000) HHV 8 in renal transplant recipients. Transpl Int 13(Suppl 1):S410–S412PubMedCrossRefGoogle Scholar
  24. Dockell DH, Paya CV (2001) Human herpesvirus-6 and-7 in transplantation. Rev Med Virol 11:23–36CrossRefGoogle Scholar
  25. Domınguez-Gil B, Morales JM (2009) Transplantation in the patient with hepatitis C. Transpl Int 22:1117–1131PubMedCrossRefGoogle Scholar
  26. Doyle AM, Warburton KM, Goral S, Blumberg E, Grossman RA, Bloom RD (2006) 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalo-virus disease compared to a 12-week course. Transplantation 81:1106–1111PubMedCrossRefGoogle Scholar
  27. Drachenberg CB, Hirsch HH, Ramos E, Papadimitriou JC (2005) Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol 36:1245–1255PubMedCrossRefGoogle Scholar
  28. Fabrizi F, Martin P, Dixit V, Kanwal F, Dulai G (2005) HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 5:2913–2921PubMedCrossRefGoogle Scholar
  29. Fehr T, Bossart W, Wahl C, Binswanger U (2002) Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature. Transplantation 73(4):608–611PubMedCrossRefGoogle Scholar
  30. Fischer SA, Graham MB, Kuehnert MJ et al (2006) Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354:2235–2249PubMedCrossRefGoogle Scholar
  31. Fischer SA, Lu K, AST Infectious Diseases Community of Practice (2013) Screening of donor and recipient in solid organ transplantation. Am J Transplant 13:9–21PubMedCrossRefGoogle Scholar
  32. Fishman JA (2007) Infection in solid organ transplant recipients. N Engl J Med 357:2601–2614PubMedPubMedCentralCrossRefGoogle Scholar
  33. Frassetto LA, Tan-Tam C, Stock PG (2009) Renal transplantation in patients with HIV. Nat Rev Nephrol 5(10):582–589PubMedPubMedCentralCrossRefGoogle Scholar
  34. Gelfand MS. Clinical Manifestations and diagnosis of Listeria monocytogenes infection. In: Up to Date, Post TW (ed) Up to Date. Waltham. Accessed June 2016Google Scholar
  35. Green M, Avery R, Preiksaitis J (2004) Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant 4(Suppl 10):160–163Google Scholar
  36. Gulley ML, Tang W (2010) Using epstein-barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev 23(2):350–366PubMedPubMedCentralCrossRefGoogle Scholar
  37. Hagerty JA, Ortiz J, Reich D, Manzarbeitia C (2003) Fungal infections in solid organ transplant patients. Surg Infect 4(3):263–271CrossRefGoogle Scholar
  38. Hariharan S (2006) BK virus nephritis after renal transplantation. Kidney Int 69:655–662PubMedCrossRefGoogle Scholar
  39. Hirsch H, Brennan D, Drachenberg C, Ginevri F, Gordon J, Limaye AP, Mihatsch M, Nickeleit V, Ramos E, Randhawa P, Shapiro R, Steiger J, Suthanthiran M, Trofe J (2005) Polyoma-virus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277–1286PubMedCrossRefGoogle Scholar
  40. Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T (2004) Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 47:1550–1556PubMedCrossRefGoogle Scholar
  41. Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GF, Vimalachandra D, Webster AC (2005) Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 4:CD003774Google Scholar
  42. Humar A, Snydman D (2009) AST infectious diseases community of practice: cytomegalovirus in solid organ transplant recipients. Am J Transplant 9(Suppl 4):S78–S86PubMedCrossRefGoogle Scholar
  43. Humar A, Ramcharen T, Denny R, Gillingham KJ, Payne WD, Matas AJ (2001) Are wound complications after a kidney transplant more common with modern immunosuppression. Transplantation 72(12):1920–1923PubMedCrossRefGoogle Scholar
  44. Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P (2010) The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 10:1228–1237PubMedCrossRefGoogle Scholar
  45. Huprikar S, Danziger-Isakov L, Ahn J et al (2015) Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant 15:1162–1172PubMedCrossRefGoogle Scholar
  46. Ison MG (2006) Adenovirus infections in transplant recipients. Clin Infect Dis 43:331–339PubMedCrossRefGoogle Scholar
  47. Janus N, Vacher LV, Karie S et al (2008) Vaccination and chronic kidney disease. Nephrol Dial Transplant 23:800–807PubMedCrossRefGoogle Scholar
  48. Josephson MA, Williams JW, Chandraker A, Randhawa PS (2006) Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis 8:95–101PubMedCrossRefGoogle Scholar
  49. Kamar N, Weclawiack H, Guilbeaud-Frugier C et al (2012) Hepatitis E virus and the kidney in solid-organ-transplant patients. Transplantation 93:617–623PubMedGoogle Scholar
  50. Karuthu S, Blumberg EA (2012) Common infections in kidney transplant recipients. Clin J Am Soc Nephrol 7:2058–2070PubMedCrossRefGoogle Scholar
  51. Kausz K, Pahari D (2004) The value of vaccination in chronic kidney disease. Semin Dial 17(1):9–11PubMedCrossRefGoogle Scholar
  52. KDIGO (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9:S1–S155Google Scholar
  53. Khoury JA, Brennan DC (2005) Infectious complications in kidney transplant recipients: review of the literature. Saudi J Kidney Dis Transplant 16(4):453–497Google Scholar
  54. Kidd IM, Clark DA, Sabin CA et al (2000) Prospective study of human betaherpesviruses after renal transplantation. Association of human herpesvirus 7 and cytomegalovirus co- infection with cytomegalovirus disease and increased rejection. Transplantation 69(11):2400–2404PubMedCrossRefGoogle Scholar
  55. Kliem V, Fricke L, Wollbrink T, Burg M, Radermacher J, Rohde F (2008) Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial. Am J Transplant 8:975–983PubMedCrossRefGoogle Scholar
  56. Kobayashi M, Bennett NM, Gierke R et al (2015) Intervals between PCV13 and PPSV23 vaccines: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 64(34):944–947PubMedCrossRefGoogle Scholar
  57. Kotton CN, Fishman JA (2005) Viral infection in the renal transplant recipient. J Am Soc Nephrol 16:1758–1774PubMedCrossRefGoogle Scholar
  58. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov HA (2013) Transplantation society international CMV consensus group: international consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 96:333–360PubMedCrossRefGoogle Scholar
  59. Kovacs CS, Koval CE, van Duin D et al (2014) Selecting suitable solid organ transplant donors: reducing the risk of donor-transmitted infections. World J Transplant 4(2):43–56PubMedCrossRefGoogle Scholar
  60. Lapchik MS, Filho A, Pestana JO, Silva Filho AP, Wey SB (1992) Risk factors for nosocomial urinary tract and postoperative wound infections in renal transplant patients: a matched-pair case-control study. J Urol 147(4):944–948CrossRefGoogle Scholar
  61. Len O, Garzoni C, Lumbreras C et al (2014) Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect 20:10–18PubMedCrossRefGoogle Scholar
  62. Levitsky J, Doucette K, the AST Infectious Diseases Community of Practice (2013) Viral hepatitis in solid organ transplant recipients. Am J Transplant 13:147–168PubMedCrossRefGoogle Scholar
  63. Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M (2000) Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 356:645–649PubMedCrossRefGoogle Scholar
  64. Manez R, Breinig MC, Linden P, Wilson J, Torre-Cisneros J, Kusne S, Dummer S, Ho M (1997) Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 176:1462–1467PubMedCrossRefGoogle Scholar
  65. Martin SI, Fishman JA (2013) American Society of Transplantation and American Society of Transplant Surgeons, pneumocystis pneumonia in solid organ transplantation. Am J Transplant 13:272–279PubMedCrossRefGoogle Scholar
  66. McLaughlin K, Wu C, Fick G, Muirhead N, Hollomby D, Jevnikar A (2002) Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection. Transplantation 74(6):813–816PubMedCrossRefGoogle Scholar
  67. Mgbako O, Glazier A, Blumberg E et al (2013) Allowing HIV-positive organ donation: ethical, legal and operational considerations. Am J Transplant 13(7):1636–1642PubMedCrossRefGoogle Scholar
  68. MMWR (2003) ATS, CDC, IDSA, treatment of tuberculosis 52(rr11):1–77Google Scholar
  69. Morales JM, Marcé R, Andres A, Domínguez-Gil B, Campistol JM, Gallego R, Gutierrez A, Gentil MA, Oppenheimer F, Samaniego ML, Muñoz-Robles J, Serón D (2010) Renal transplantation in patients with hepatitis C virus antibody. A long national experience. NDT Plus 3:ii41–ii46PubMedPubMedCentralGoogle Scholar
  70. Muller E, Barday Z, Mendelson M et al (2015) HIV-positive-to-HIV-positive kidney transplantation-results at 3–5 years. N Engl J Med 372:613–620PubMedPubMedCentralCrossRefGoogle Scholar
  71. Mwintshi K, Brennan DC (2007) Prevention and management of cytomegalovirus infection in solid-organ transplantation. Expert Rev Anti-Infect Ther 5(2):295–304PubMedCrossRefGoogle Scholar
  72. Nakamura N, Tamaru S, Ohshima K, Tanaka M, Arakaki Y, Miyauchi T (2005) Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc 37:1779–1782PubMedCrossRefGoogle Scholar
  73. Owers DS, Webster AC, Strippoli GF, Kable K, Hodson EM (2013) Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev (2):CD005133Google Scholar
  74. Patel R, Paya C (1997) Infections in solid-organ transplant patients. Clin Microbiol Rev 10:86–124PubMedPubMedCentralGoogle Scholar
  75. Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Pescovitz MD (2004) Valganciclovir solid organ transplant study group: efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cyto-megalovirus disease in solid organ transplant recipients. Am J Transplant 4:611–620PubMedCrossRefGoogle Scholar
  76. Pham TT, Burchette JR Jr, Hale LP (2003) Fatal disseminated adenovirus infections in immunocompromised patients. Am J Clin Pathol 120:575–583PubMedCrossRefGoogle Scholar
  77. Phillips T, Jacobs R, Ellis EN (2004) Polyoma nephropathy and progressive multifocal leukoencephalopathy in a renal transplant recipient. J Child Neurol 19(4):301–304PubMedCrossRefGoogle Scholar
  78. Pouria S, State OI, Wong W, Hendry BM (1998) CMV infection is associated with transplant renal artery stenosis. QJM 91:185–189PubMedCrossRefGoogle Scholar
  79. Ramos A, Asensio A, Munez E et al (2008) Incisional surgical site infection in kidney transplantation. Urology 72(1):119–123CrossRefGoogle Scholar
  80. Randhawa P, Brennan DC (2006) BK virus in transplant recipients: an overview and update. Am J Transplant 6:2000–2005PubMedCrossRefGoogle Scholar
  81. Regamy N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P (1998) Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 339:1358–1363CrossRefGoogle Scholar
  82. Sagedal S, Hartmann A, Nordal KP et al (2004) Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 66(1):329–337PubMedCrossRefGoogle Scholar
  83. San Juan R, Aguado JM, Lumbreras C, Fortun J, Muñoz P, Gavalda J, Lopez-Medrano F, Montejo M, Bou G, Blanes M, Ramos A, Moreno A, Torre-Cisneros J, Carratalá J, RESITRA Network of the Spanish Study Group of Infection in Transplantation (2008) Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. Clin Infect Dis 47:875–882PubMedCrossRefGoogle Scholar
  84. Sawinski D, Kaur N, Ajeti A, Trofe-Clark J, Lim M, Bleicher M, Goral S, Forde KA, Bloom RD (2016) Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents. American Journal of Transplantation 16(5):1588–1595PubMedCrossRefGoogle Scholar
  85. Seem DL, Lee I, Umscheid CA et al (2013) PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep 128(4):247–343PubMedPubMedCentralCrossRefGoogle Scholar
  86. Shahinian V, Rajaraman S, Borucki M, Grady J, Hollander WM, Ahuja TS (2000) Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis 35(5):884–888PubMedCrossRefGoogle Scholar
  87. Singh N, Carrigan D (1996) Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 124:1065–1071PubMedCrossRefGoogle Scholar
  88. Snyder JJ, Israni AK, Peng Y et al (2009) Rates of first infection following kidney transplant in the United States. Kidney Int 75:317–326PubMedCrossRefGoogle Scholar
  89. Spelman D. Treatment of Nocardia. In: Up to Date, Post TW (ed) Up to date, Waltham. Accessed June 2016Google Scholar
  90. Srinivasan A, Burton EC, Kuehnert MJ et al (2005) Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 352:1103–1111PubMedCrossRefGoogle Scholar
  91. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesuldo L, Schena FP, Grandaliano G (2005) Sirolimus for Kaposi’s sarcoma in renal transplant recipients. N Engl J Med 352:1317–1323PubMedCrossRefGoogle Scholar
  92. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME (2010) Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 363:2004–2014PubMedPubMedCentralCrossRefGoogle Scholar
  93. Strippoli GFM, Hodson EM, Jones CA, Craig JC (2006) Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Transplantation 81:139–145PubMedCrossRefGoogle Scholar
  94. Tan HH, Goh CL (2006) Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol 7:13–29PubMedCrossRefGoogle Scholar
  95. Tanabe K, Kitani R, Takahashi K et al (1998) Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients. Transplant Proc 30:3168–3170PubMedCrossRefGoogle Scholar
  96. Taylor AL, Marcus R, Bradley JA (2005) Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 56(1):155–167PubMedCrossRefGoogle Scholar
  97. Tong CYW, Bakran A, Peiris JSM, Muir P, Simon Herrington C (2002) The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 74(4):576–578PubMedCrossRefGoogle Scholar
  98. Trofe J, Gaber LW, Stratta RJ, Shokouh-Amin MH, Vera SR, Alloway RR, Lo A, Gaber AO, Eqidi MF (2003) Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis 5:21–28PubMedCrossRefGoogle Scholar
  99. United States Renal Data System USRDS annual data report (2015) Epidemiology of kidney disease in the unites states. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, BethesdaGoogle Scholar
  100. Waggoner J, Deresinski S (2013) Rare and emerging viral infection in the transplant population. In: Safdar A (ed) Principles and practice of transplant infectious diseases. Springer Medizin, BerlinGoogle Scholar
  101. Weikert BC, Blumberg EA (2008) Viral infection after renal transplantation: surveillance and management. Clin J Am Soc Nephrol 3(Suppl 2):S76–S86PubMedPubMedCentralCrossRefGoogle Scholar
  102. Wilson JP, Turner HR, Kirchner KA, Chapman SW (1989) Nocardial infections in renal transplant recipients. Medicine 68(1):38–57PubMedCrossRefGoogle Scholar
  103. Wyner LM (1994) The evaluation and management of urinary tract infections in recipients of solid organ transplants. Semin Urol 12(2):134–139PubMedGoogle Scholar
  104. Yu VL. Treatment and prevention of Legionella infection. In: Up to Date, Post TW (ed) Up to Date, Waltham. Accessed June 2016Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Puja Nambiar
    • 1
    Email author
  • Randi Silibovsky
    • 2
  • Katherine A. Belden
    • 2
  1. 1.Cleveland Clinic, Division of Infectious DiseasesClevelandUSA
  2. 2.Sidney Kimmel Medical College at Thomas Jefferson University HospitalPhiladelphiaUSA

Personalised recommendations